In mouse models of ischemic and cisplatin-induced acute kidney injury, intravenous administration of siRNA against p53 reduces cellular p53 and attenuates p53-mediated apoptosis (Molitoris et al. 2009). Here, TP53 is linked to acute kidney injury.